Vancomycin Market: Current Analysis and Forecast (2022-2030)
Emphasis on Type (Daptomycin, Linezolid, Quinupristin, Ampicillin, Chloramphenicol, and Others); Application (Sepsis, Lung Infection, Skin Soft Tissue Infection, Colitis & Intestinal Inflammation, and Others); and Region/Country
The Vancomycin Market was valued at USD 300 million in 2021 & is expected to grow at a CAGR of 5% from 2022-2030. Vancomycin is an essential antibiotic medication that is highly in demand globally due to its effectiveness against severe bacterial infections caused by bacterial infection. As antibiotic resistance continues to rise, vancomycin remains a crucial treatment option for many infectious diseases. Furthermore, the growing incidence of healthcare-associated infections and the aging population’s vulnerability to infections are also contributing factors to the high demand for vancomycin. Despite concerns about potential side effects and the availability of alternative treatment options, efforts to improve the drug’s safety and formulation, along with the ongoing need for effective antibiotic treatment, are expected to maintain the growth trajectory of the vancomycin market.
Vancomycin works by inhibiting the bacterial cell wall’s synthesis, which prevents the bacteria from multiplying and spreading. Furthermore, the rising demand for antibiotics globally and the increasing prevalence of infections by several pharmaceutical companies manufacturing and distributing vancomycin globally will drive the growth of the market.
Some of the major players operating in the market include Pfizer Inc.; Lilly; Viamericas Corporation; Alvogen; Aphios Corporation; Enanta Pharmaceuticals, Inc.; LEGOCHEM BIOSCIENCES, Inc.; LYTIX BIOPHARMA AS; MGB Biopharma; Microbiotix Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst type, the daptomycin segment held a dominating share of the market in 2021.”
Based on type, the market is segmented into daptomycin, linezolid, quinupristin, ampicillin, chloramphenicol, and others. Amongst these, the daptomycin category dominated the market in 2021. This is due to the increasing prevalence of antibiotic-resistant infections, favorable regulatory environment, increasing demand for novel antibiotics, and rise in hospital-acquired infections. For instance, The Centers for Disease Control and Prevention (CDC) estimates that HAIs cause an estimated 1.7 million infections and 99,000 deaths annually in American hospitals alone.
“Amongst application, lung infections held the majority share of the market in 2021.”
By application, the market is bifurcated into sepsis, lung infection, skin soft tissue infection, colitis & intestinal inflammation, and others. Among these, the lung infection category captured the majority share of the vancomycin market in 2021. This is mainly due to the rising cases of pneumonia, increasing incidence of hospital-acquired infections and the rise of drug-resistant bacterial infections have led to an increased demand for vancomycin. For instance, as per UNICEF, around 1,400 cases of pneumonia per 100,000 children, or 1 case per 71 children every year diagnosed globally.
“APAC is expected to grow at the fastest rate in 2021”
APAC is expected to grow at the fastest rate in 2021 due to the rising incidence of bacterial infections, increasing awareness about infectious diseases, and the growing use of vancomycin in hospitals and other healthcare facilities. The APAC region is also witnessing an increase in the number of geriatric patients, who are more susceptible to infections, and this is expected to further boost the demand for vancomycin. Moreover, the increasing prevalence of antibiotic-resistant bacteria is likely to drive the demand for vancomycin, which is an effective treatment option for resistant strains of bacteria.
Vancomycin Market Report Coverage
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
Customization Options:
The global Vancomycin Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the Vancomycin Market Analysis (2022-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global Vancomycin Market were the three major steps undertaken to create and analyze the adoption of vancomycins in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global Vancomycin Market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the Vancomycin Market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the vancomycin market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as type and application. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the Vancomycin Market. Further, we conducted factor analysis using dependent and independent variables such as type and application of the Vancomycin Market. A thorough analysis was conducted of demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Vancomycin Market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Vancomycin Market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the Vancomycin Market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global Vancomycin Market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global Vancomycin Market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the type and application in the global Vancomycin Market.
The main objective of the Global Vancomycin Market Study
The current & future market trends of the global Vancomycin Market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the vancomycin market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments.
- Segments in the study include areas of the type and application.
- Define and analysis of the regulatory framework for the vancomycin industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the vancomycin market for the major region
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
- Company profiles of the Vancomycin Market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
